STOCKHOLM, Sweden (LifeSiteNews) – A group of 16 Swedish doctors and researchers demanded that Pfizer’s COVID injections throughout the nation be “paused until risk/benefit calculations are made for all age groups” while referencing “extensive research fraud” in the pharmaceutical company’s clinical trials.
The group’s statement in a November 5 press release came in light of a whistleblower’s testimony to the prestigious British Medical Journal (BMJ), alleging that a Pfizer subcontractor company had falsified data, unblinded trial participants, and neglected the timely follow-up of subjects experiencing adverse events as they conducted a Pfizer COVID-19 vaccine trial in the fall of 2020.
Brook Jackson, a “trained clinical trial auditor” with more than “15 years’ experience in clinical research coordination and management,” worked for Ventavia Research Group of Texas for two weeks in September 2020 and was fired the day she raised her concerns to the U.S. Food and Drug Administration (FDA).
Jackson, whose testimony was corroborated by former colleagues, raised a number of issues to the FDA, including:
- Participants placed in a hallway after injection and not being monitored by clinical staff
- Lack of timely follow-up of patients who experienced adverse events
- Protocol deviations not being reported
- Vaccines not being stored at proper temperatures
- Mislabeled laboratory specimens, and
- Targeting of Ventavia staff for reporting these types of problems.
Referencing the BMJ’s report, the Swedish doctors described the contents as “extremely serious.”
“It undermines confidence in Pfizer, which is responsible for testing the vaccine and for the safety of the vaccine currently being used in Swedes, hundreds of thousands of whom are children,” they wrote.
The 16 signatories also noted the “gigantic” scale “of the number of reported suspected adverse reactions to the COVID” injections as a cause for concern. In Sweden alone, “83,744 suspected adverse reactions have been reported” since injections commenced 10 months ago.
Such a figure “is more than 10 times more than all the adverse reactions reported per year in the preceding years for all medicines and vaccines, totaling some 25,000 substances,” they stated.
Meanwhile, “some 20 studies have shown that the vaccine’s efficacy is very weak,” added the signatories, further attacking the need for vaccination campaigns. Their argument was supported recently by Dr. Peter Doshi, an associate professor of pharmaceutical health services research at the University of Maryland School of Pharmacy and associate editor of the BMJ, who testified against COVID vaccine efficacy.
Consequently, the signatories stressed that due to the combined weight of Jackson’s testimony, along with the adverse effects and proof of lack of efficacy, the injection campaign must be halted. “Our position is taken in the light of the revelation in the BMJ and what we know today about the risks to patients,” they said.
“The strong suspicion that parts of the clinical trial for the Pfizer vaccine were not conducted in a scientifically acceptable manner and where the study results cannot be considered reliable, combined with the large number of reported suspected adverse reactions following vaccination, many of a serious nature, is of deep concern to us as physicians, scientists and immunologists,” they wrote.
Highlighting particularly the “extremely low risk of serious disease” COVID-19 posed to children, the signatories noted that the injections present the “risk of serious side effects” to children.
“The fact that the vaccine’s efficacy has already declined considerably after a few months and is weak against the delta variant of the virus contributes to our conclusion that COVID vaccination in Sweden should be paused until risk/benefit calculations are made for all age groups,” they said.
Signatory notes ‘rapid decline’ in jab efficacy, studies warn of health concerns
“At four to six months, the vaccines were only reducing the relative risk of infection by 48%,” he noted, later adding that by nine months, Pfizer’s injection is “no longer offering any protection whatsoever against symptomatic COVID-19.”
Another recent study, undertaken by researchers in two Swedish universities and using the abortion-derived HEK-293 cell line, observed that the spike proteins delivered by the mRNA COVID injections actually harmed physical health. The “spike protein significantly inhibits DNA damage repair,” the authors attested.
“Our findings reveal a potential molecular mechanism by which the spike protein might impede adaptive immunity and underscore the potential side effects of full-length spike-based vaccines,” they continued.
Meanwhile, the amount of adverse effects post-injection in the United States continues to grow, as documented by the Centers for Disease Control and Prevention (CDC). Data from December 14, 2020 through October 29, 2021, record a total of 856,919 adverse events after COVID-19 injections.
Children’s Health Defense reported that “of the 8,284 U.S. deaths reported as of Oct. 29, 10% occurred within 24 hours of vaccination, 15% occurred within 48 hours of vaccination and 26% occurred in people who experienced an onset of symptoms within 48 hours of being vaccinated.”
Such figures could be only a small representative of the true total, as a 2010 report submitted to the U.S. Department of Health & Human Services’ (HHS) Agency for Healthcare Research and Quality (AHRQ) warned that VAERS caught “fewer than 1% of vaccine adverse events.”
The CDC has itself admitted finding a “likely association” between heart inflammation in adolescents and young adults after vaccination with an experimental mRNA COVID shot. Some teens have died shortly after receiving their shots.
The list of the 16 signatories is found below:
Nils Littorin, MD; Ph.D. in clinical microbiology
Magnus Burling, specialist in general medicine
Sture Blomberg, specialist in anaesthesia and intensive care; associate professor
Ragnar Hultborn, specialist in oncology; professor emeritus
Lilian Weiss, specialist in general surgery; associate professor
Ann-Cathrin Engwall, immunologist and virologist; Ph.D. in molecular cell biology with an immunological focus
Sebastian Rushworth, intern
Maria Papadopoulou, eye specialist
Carina Ljungfelt, specialist in general medicine
Christina Malm, specialist in general medicine
Bo Jonsson, specialist in general psychiatry; MD
Anette Stahel, MSc in biomedicine
Nina Yderberg, specialist in child and adolescent psychiatry
Dinu Dusceac, specialist in cardiology; Ph.D.
Margareta Andersson, specialist in general medicine
Hanna Åsberg, specialist in general medicine